United States Drug Enforcement Administration

On August 1, 2023, the Drug Enforcement Administration (DEA) and U.S. Food and Drug Administration (FDA) issued a joint letter updating the public on the ongoing prescription stimulant shortages impacting patients across the United States and actions to resolve these shortages.  The DEA and FDA are committed to working together on this issue and providing up-to-date information to the public.  We will continue to do all we can to prevent stimulant drug shortages, limit their impact, and resolve them as quickly as possible.